Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BF.7.21ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.21ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.21NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.7.13.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.7.13.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.13.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.13.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.37ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.37ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.37ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.37NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CK.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CK.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CK.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CK.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CM.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CM.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CM.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBC.1.3.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBC.1.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBC.1.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBC.1.3.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.11.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.11.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.11.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.11.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XDLORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XDLENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDLENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDLNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.17ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.17NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.29.1 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.29.1 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.29.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.29.1 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.29.2 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.29.2 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.29.2 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
AY.29.2 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-6672.85US
BC.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-2346.71France
BC.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BC.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BC.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.10.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.10.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.10.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used